ID   EPHAA_HUMAN             Reviewed;        1008 AA.
AC   Q5JZY3; A4FU89; J3KPB5; Q6NW42;
DT   27-SEP-2005, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2013, sequence version 2.
DT   10-MAY-2017, entry version 133.
DE   RecName: Full=Ephrin type-A receptor 10;
DE            EC=2.7.10.1;
DE   Flags: Precursor;
GN   Name=EPHA10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM
RP   2), ALTERNATIVE SPLICING, FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=15777695; DOI=10.1016/j.bbagen.2005.01.011;
RA   Aasheim H.-C., Patzke S., Hjorthaug H.S., Finne E.F.;
RT   "Characterization of a novel Eph receptor tyrosine kinase, EphA10,
RT   expressed in testis.";
RL   Biochim. Biophys. Acta 1723:1-7(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 501-1008 (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-150; LYS-220; ILE-281; PRO-630;
RP   ARG-775 AND THR-956.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Receptor for members of the ephrin-A family. Binds to
CC       EFNA3, EFNA4 and EFNA5. {ECO:0000269|PubMed:15777695}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- INTERACTION:
CC       Q8N9N5:BANP; NbExp=3; IntAct=EBI-10244652, EBI-744695;
CC       Q13557:CAMK2D; NbExp=3; IntAct=EBI-10244652, EBI-351018;
CC       Q13643:FHL3; NbExp=3; IntAct=EBI-10244652, EBI-741101;
CC       Q12800:TFCP2; NbExp=3; IntAct=EBI-10244652, EBI-717422;
CC   -!- SUBCELLULAR LOCATION: Isoform 1: Cell membrane {ECO:0000305};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 3: Cell membrane {ECO:0000305};
CC       Single-pass type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Isoform 2: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q5JZY3-1; Sequence=Displayed;
CC       Name=2; Synonyms=Epha10s;
CC         IsoId=Q5JZY3-2; Sequence=VSP_015772, VSP_015773;
CC       Name=3; Synonyms=Epha10*;
CC         IsoId=Q5JZY3-3; Sequence=VSP_015774, VSP_015775;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay.;
CC   -!- TISSUE SPECIFICITY: Mainly expressed in testis.
CC       {ECO:0000269|PubMed:15777695}.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. Ephrin receptor subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI12934.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ872185; CAI43321.1; -; Genomic_DNA.
DR   EMBL; AJ781169; CAG77605.1; -; mRNA.
DR   EMBL; AC104336; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC067734; AAH67734.1; -; mRNA.
DR   EMBL; BC112933; AAI12934.1; ALT_INIT; mRNA.
DR   CCDS; CCDS41305.1; -. [Q5JZY3-1]
DR   CCDS; CCDS425.1; -. [Q5JZY3-2]
DR   RefSeq; NP_001092909.1; NM_001099439.1. [Q5JZY3-1]
DR   RefSeq; NP_775912.2; NM_173641.2. [Q5JZY3-2]
DR   UniGene; Hs.129435; -.
DR   ProteinModelPortal; Q5JZY3; -.
DR   SMR; Q5JZY3; -.
DR   BioGrid; 129927; 5.
DR   IntAct; Q5JZY3; 4.
DR   STRING; 9606.ENSP00000362139; -.
DR   ChEMBL; CHEMBL2363043; -.
DR   iPTMnet; Q5JZY3; -.
DR   PhosphoSitePlus; Q5JZY3; -.
DR   BioMuta; EPHA10; -.
DR   DMDM; 476007830; -.
DR   EPD; Q5JZY3; -.
DR   PaxDb; Q5JZY3; -.
DR   PeptideAtlas; Q5JZY3; -.
DR   PRIDE; Q5JZY3; -.
DR   DNASU; 284656; -.
DR   Ensembl; ENST00000319637; ENSP00000316395; ENSG00000183317. [Q5JZY3-2]
DR   Ensembl; ENST00000373048; ENSP00000362139; ENSG00000183317. [Q5JZY3-1]
DR   GeneID; 284656; -.
DR   KEGG; hsa:284656; -.
DR   UCSC; uc001cbw.5; human. [Q5JZY3-1]
DR   CTD; 284656; -.
DR   DisGeNET; 284656; -.
DR   GeneCards; EPHA10; -.
DR   HGNC; HGNC:19987; EPHA10.
DR   HPA; HPA027497; -.
DR   MIM; 611123; gene.
DR   neXtProt; NX_Q5JZY3; -.
DR   OpenTargets; ENSG00000183317; -.
DR   PharmGKB; PA134938798; -.
DR   eggNOG; KOG0196; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118975; -.
DR   HOGENOM; HOG000233856; -.
DR   HOVERGEN; HBG062180; -.
DR   InParanoid; Q5JZY3; -.
DR   KO; K08897; -.
DR   TreeFam; TF314013; -.
DR   Reactome; R-HSA-2682334; EPH-Ephrin signaling.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   ChiTaRS; EPHA10; human.
DR   GeneWiki; EPHA10; -.
DR   GenomeRNAi; 284656; -.
DR   PRO; PR:Q5JZY3; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000183317; -.
DR   CleanEx; HS_EPHA10; -.
DR   ExpressionAtlas; Q5JZY3; baseline and differential.
DR   Genevisible; Q5JZY3; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:InterPro.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005003; F:ephrin receptor activity; IEA:InterPro.
DR   GO; GO:0005005; F:transmembrane-ephrin receptor activity; IDA:UniProtKB.
DR   GO; GO:0048013; P:ephrin receptor signaling pathway; TAS:Reactome.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.120.260; -; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR027936; Eph_TM.
DR   InterPro; IPR001090; Ephrin_rcpt_lig-bd_dom.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR008979; Galactose-bd-like.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR011641; Tyr-kin_ephrin_A/B_rcpt-like.
DR   InterPro; IPR016257; Tyr_kinase_ephrin_rcpt.
DR   InterPro; IPR001426; Tyr_kinase_rcpt_V_CS.
DR   Pfam; PF14575; EphA2_TM; 1.
DR   Pfam; PF01404; Ephrin_lbd; 1.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   Pfam; PF00536; SAM_1; 1.
DR   PIRSF; PIRSF000666; TyrPK_ephrin_receptor; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00615; EPH_lbd; 1.
DR   SMART; SM01411; Ephrin_rec_like; 1.
DR   SMART; SM00060; FN3; 2.
DR   SMART; SM00454; SAM; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   SUPFAM; SSF49265; SSF49265; 1.
DR   SUPFAM; SSF49785; SSF49785; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS51550; EPH_LBD; 1.
DR   PROSITE; PS50853; FN3; 2.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00790; RECEPTOR_TYR_KIN_V_1; 1.
DR   PROSITE; PS00791; RECEPTOR_TYR_KIN_V_2; 1.
DR   PROSITE; PS50105; SAM_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cell membrane; Complete proteome;
KW   Glycoprotein; Kinase; Membrane; Nucleotide-binding; Polymorphism;
KW   Receptor; Reference proteome; Repeat; Secreted; Signal; Transferase;
KW   Transmembrane; Transmembrane helix; Tyrosine-protein kinase.
FT   SIGNAL        1     33       {ECO:0000255}.
FT   CHAIN        34   1008       Ephrin type-A receptor 10.
FT                                /FTId=PRO_0000042157.
FT   TOPO_DOM     34    565       Extracellular. {ECO:0000255}.
FT   TRANSMEM    566    586       Helical. {ECO:0000255}.
FT   TOPO_DOM    587   1008       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       35    216       Eph LBD. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00883}.
FT   DOMAIN      340    452       Fibronectin type-III 1.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      456    554       Fibronectin type-III 2.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00316}.
FT   DOMAIN      645    900       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      933    997       SAM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00184}.
FT   CARBOHYD    311    311       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    486    486       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VAR_SEQ     284    295       ACPPGFYKVSPR -> GIQLAGGRGVGV (in isoform
FT                                2). {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15777695}.
FT                                /FTId=VSP_015772.
FT   VAR_SEQ     296   1008       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:15777695}.
FT                                /FTId=VSP_015773.
FT   VAR_SEQ     889    892       ERPR -> LPPH (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015774.
FT   VAR_SEQ     893   1008       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_015775.
FT   VARIANT     103    103       V -> L (in dbSNP:rs34557762).
FT                                /FTId=VAR_055992.
FT   VARIANT     150    150       R -> H (in a gastric adenocarcinoma
FT                                sample; somatic mutation;
FT                                dbSNP:rs771803475).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042159.
FT   VARIANT     220    220       T -> K (in dbSNP:rs56276182).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042160.
FT   VARIANT     281    281       F -> I (in dbSNP:rs4653328).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042161.
FT   VARIANT     629    629       L -> P (in dbSNP:rs17511304).
FT                                /FTId=VAR_055993.
FT   VARIANT     630    630       L -> P. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042162.
FT   VARIANT     645    645       V -> I (in dbSNP:rs12405650).
FT                                /FTId=VAR_055994.
FT   VARIANT     749    749       G -> E (in dbSNP:rs6671088).
FT                                /FTId=VAR_055995.
FT   VARIANT     775    775       H -> R (in a breast infiltrating ductal
FT                                carcinoma sample; somatic mutation).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042163.
FT   VARIANT     807    807       R -> Q (in dbSNP:rs6670599).
FT                                /FTId=VAR_055996.
FT   VARIANT     956    956       A -> T. {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_042164.
FT   CONFLICT    458    458       D -> G (in Ref. 1; CAI43321).
FT                                {ECO:0000305}.
FT   CONFLICT    503    503       T -> A (in Ref. 1; CAI43321).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1008 AA;  109716 MW;  82D60740B7B6B9BD CRC64;
     METCAGPHPL RLFLCRMQLC LALLLGPWRP GTAEEVILLD SKASQAELGW TALPSNGWEE
     ISGVDEHDRP IRTYQVCNVL EPNQDNWLQT GWISRGRGQR IFVELQFTLR DCSSIPGAAG
     TCKETFNVYY LETEADLGRG RPRLGGSRPR KIDTIAADES FTQGDLGERK MKLNTEVREI
     GPLSRRGFHL AFQDVGACVA LVSVRVYYKQ CRATVRGLAT FPATAAESAF STLVEVAGTC
     VAHSEGEPGS PPRMHCGADG EWLVPVGRCS CSAGFQERGD FCEACPPGFY KVSPRRPLCS
     PCPEHSRALE NASTFCVCQD SYARSPTDPP SASCTRPPSA PRDLQYSLSR SPLVLRLRWL
     PPADSGGRSD VTYSLLCLRC GREGPAGACE PCGPRVAFLP RQAGLRERAA TLLHLRPGAR
     YTVRVAALNG VSGPAAAAGT TYAQVTVSTG PGAPWEEDEI RRDRVEPQSV SLSWREPIPA
     GAPGANDTEY EIRYYEKGQS EQTYSMVKTG APTVTVTNLK PATRYVFQIR AASPGPSWEA
     QSFNPSIEVQ TLGEAASGSR DQSPAIVVTV VTISALLVLG SVMSVLAIWR RPCSYGKGGG
     DAHDEEELYF HFKVPTRRTF LDPQSCGDLL QAVHLFAKEL DAKSVTLERS LGGGRFGELC
     CGCLQLPGRQ ELLVAVHMLR DSASDSQRLG FLAEALTLGQ FDHSHIVRLE GVVTRGSTLM
     IVTEYMSHGA LDGFLRRHEG QLVAGQLMGL LPGLASAMKY LSEMGYVHRG LAARHVLVSS
     DLVCKISGFG RGPRDRSEAV YTTMSGRSPA LWAAPETLQF GHFSSASDVW SFGIIMWEVM
     AFGERPYWDM SGQDVIKAVE DGFRLPPPRN CPNLLHRLML DCWQKDPGER PRFSQIHSIL
     SKMVQDPEPP KCALTTCPRP PTPLADRAFS TFPSFGSVGA WLEALDLCRY KDSFAAAGYG
     SLEAVAEMTA QDLVSLGISL AEHREALLSG ISALQARVLQ LQGQGVQV
//
